COHLHEPP RYAN (President and COO) sold 5.9% of their position (12.50K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $245.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/17/2026ACC: 0001628280-26-018934
DirectorOfficer· President and COO
Since Mar 2026
-12.50K
Net shares
Net seller
$245.7K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
8K acquired · 20.50K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+8K
Price / share
$3.79
Trade value
$30.32K
% of position
3.9%
3/16/2026
205.14K→213.14K
Common Stock
Direct
Shares
−8K
Price / share
$19.66
Trade value
$157.26K
% of position
3.8%
3/16/2026
213.14K→205.14K
Common Stock
Direct
Shares
−4.50K
Price / share
$19.66
Trade value
$88.46K
% of position
2.2%
3/16/2026
205.14K→200.64K
Total
Net shares
−4.50K
Net value
-$215.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | M · Option Exercise | +8K | $3.79 | $30.32K | 3.9% | 205.14K | 213.14K |
| Common Stock Direct | 3/16/2026 | S · Sale | −8K | $19.66 | $157.26K | 3.8% | 213.14K | 205.14K |
| Common Stock Direct | 3/16/2026 | S · Sale | −4.50K | $19.66 | $88.46K | 2.2% | 205.14K | 200.64K |
| Total | −4.50K | -$215.40K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
8K shares
Shares
−8K
Strike price
3.7898
Held after
117.33K
Exercisable
—
3/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock8K shares | 3/16/2026 | M · Option Exercise | −8K | 3.7898 | — | 117.33K |